Integration of serum surface-enhanced Raman spectroscopy with inflammatory and clinical features for non-invasive detection of endometriosis
Year: 2026
Type: article
Abstract: Background The non-invasive diagnosis of endometriosis remains challenging because conventional circulating biomarkers have limited discriminatory capacity. Serum surface-enhanced Raman spectroscopy (SERS) provides a comprehensive biochemical fingerprint that may complement established clinical markers. This study investigated the diagnostic potential of integrating serum SERS signatures with cancer antigen 125 (CA125) and systemic inflammatory indices for distinguishing endometriosis from benign gynecologic conditions. Methods This study included 200 surgical patients, comprising 120 patients with endometriosis and 80 benign gynecologic controls, alongside 40 healthy women serving as a secondary spectral reference. The surgical cohort was divided into development ( n = 140) and internal test ( n = 60) sets. Four diagnostic models were evaluated: CA125 alone, an inflammatory model incorporating C-reactive protein (CRP), systemic immune-inflammation index (SII), and prognostic nutritional index (PNI), a six-peak SERS model, and a combined model. Diagnostic performance was assessed through receiver operating characteristic analysis, calibration, and threshold-based classification. Associations between SERS-derived probabilities, inflammatory markers, and disease stage were also examined. Results Six Raman bands exhibited distinct intensity patterns across the study groups. Principal component analysis revealed differences in spectral profiles, with the first two components explaining 69.8% of the total variance. In the internal test set, the areas under the curve (AUCs) were 0.873 for CA125, 0.763 for the inflammatory model, 0.773 for SERS, and 0.907 (95% CI: 0.822–0.973) for the combined model. The combined model achieved a Brier score of 0.124, with 66.7% sensitivity, 91.7% specificity, and 76.7% accuracy at a predefined threshold of 0.72. SERS-derived probabilities were positively correlated with rASRM stage ( ρ = 0.60), SII ( ρ = 0.35), and CRP ( ρ = 0.24). Furthermore, significantly higher probabilities were observed in stage III–IV than in stage I–II endometriosis in the 36-patient stage analysis ( P = 0.0014). Conclusion Serum SERS revealed disease-associated spectral signatures related to endometriosis severity. Integrating SERS with CA125 and inflammatory indices achieved the highest observed diagnostic discrimination and high specificity in internal testing, highlighting the potential of multimodal serum profiling as a complementary approach to endometriosis assessment.
Source: Frontiers in Medicine
Authors: Zhimiao Bai, Yufeng Liu, Xue Zhou
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236030492
